Last week, we reported that the Scandinavian Journal of Immunology had noted that a 2002 paper by Silvia Bulfone-Paus and colleagues had been retracted, but hadn’t yet published the retraction notice. A commenter tipped us off this week that the notice is out:
The retraction notices for papers by Silvia Bulfone-Paus continue to appear. Yesterday, the Journal of Immunology posted notices for these three previously accepted retractions by the researcher, work at whose Borstel Centre lab is under investigation for misconduct. The IL-15 receptor alpha chain signals through association with Syk in human B cells (2001, cited 58 … Continue reading Three more Bulfone-Paus retraction notices out, in Journal of Immunology
There was more news today about papers co-authored by Silvia Bulfone-Paus, whose lab at Research Centre Borstel has been under investigation for scientific misconduct. The EMBO Journal, which we reported last month had accepted the retraction of a 2005 Bulfone-Paus paper that has been cited 37 times, published the retraction notice for the study today: … Continue reading In retraction notice, Bulfone-Paus “declares” data and conclusions confirmed; journals accept six more retractions
A journal has accepted the sixth retraction of a paper co-authored by Silvia Bulfone-Paus, the Research Centre Borstel announced late last week. Borstel has been investigating allegations that two of Bulfone-Paus’s former postdocs manipulated images. The paper, in the Scandinavian Journal of Immunology, is titled
About two weeks ago, we reported on the first retraction of a paper co-authored by Silvia Bulfone-Paus, whose work at her Research Center Borstel lab is being investigated for misconduct. On Friday, Borstel announced that journals had accepted four more retractions of papers by Bulfone-Paus’s group. Three of those papers are in the Journal of … Continue reading Four more Bulfone-Paus paper retractions accepted
At least one of the dominoes may be falling from a scandal at Research Center Borstel. Retraction Watch has learned that one of six papers that an investigation found to include data manipulation will be retracted by the Journal of Leukocyte Biology. The paper, “ATP induces P2X7 receptor-independent cytokine and chemokine expression through P2X1 and … Continue reading Paper by Silvia Bulfone-Paus to be retracted
A group of researchers at Harbin Medical University in China has had a third paper retracted, making for a tale of three notices. The first retraction appeared in April 2017 as one of more than 100 from Tumor Biology for fake peer review. The second, for “Functions as a Tumor Suppressor in Osteosarcoma by Targeting … Continue reading Group in China up to three retractions, ostensibly for three different reasons
We’ve written about mega-corrections that allow scientists to retrace virtually all of their steps yet preserve their publications as supposedly legitimate. And we’ve seen plenty of corrections that allow authors to assert that their conclusions are correct when evidently important pieces of data are themselves unreliable. Now comes a correction that seems to us to … Continue reading Correction for MD Anderson’s Bharat Aggarwal arches eyebrows for the right reasons
In May, we broke the story of Edward Shang, a weight loss surgeon who made up most, if not all, of the patients he reported on in at least one study. We’ve been following the case since then, including three more retractions in the Journal of Parenteral and Enteral Nutrition (JPEN). As we noted in … Continue reading Hmmm: SAGE’s attorney explains why weight loss retraction notices said less than those of other journals
For some journals, thorough retraction notices are the rule — and, when misconduct is involved, the price authors pay for abusing the trust of the editors and the readers. Others seem to take a more casual approach. Guess which we think is best. Consider the case of a group of researchers in China led by … Continue reading Why retraction notices matter: Group’s repeated misuse of figures gets different play from five journals